JOHNSON & JOHNSON is 452.0x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($573.98 B vs $1.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRVI | JNJ |
|---|---|---|
| Market cap | $1.27 B | $573.98 B |
| US-listed rank | #2462 | #20 |
| Revenue (latest FY) | $185.74M | $94.19B |
| Net income (latest FY) | -$130.80M | $26.80B |
| Net margin | -70.4% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 393 | 984 |
JOHNSON & JOHNSON is 452.0x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($573.98 B vs $1.27 B).
In their latest fiscal years, MARAVAI LIFESCIENCES HOLDINGS, INC. reported $185.74M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: MARAVAI LIFESCIENCES HOLDINGS, INC. and JOHNSON & JOHNSON, or browse the full rankings.